TMIC-35. IDH1 MUTATION IN GLIOMA REPROGRAMS EARLY MYELOID DIFFERENTIATION IN THE BONE MARROW (BM) TO PRODUCE NON-IMUNESUPPRESSIVE NEUTROPHILS

Gliomas are the most common primary brain tumors; patients exhibit a poor prognosis. Mutations in isocitrate dehydrogenase (mIDH) are present in most patients with lower grade glioma (LGG), and are correlated with better prognosis and survival. We postulated that mIDH1 induces epigenetic reprogrammi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Alghamri, Mahmoud, Castro, Maria, Lowenstein, Pedro, Kamran, Neha, Kadiyala, Padma, Avvari, Ruthvik, Zhang, Li
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Tumor Microenvironment
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846775/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.1069
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados